Vast Therapeutics Inc. - Company Profile - BCIQ

Articles
Current Editions
Search Archives
BCIQ
Conferences
- China Healthcare Summit
- Bio€quity Europe
White Papers

Free Trial / Subscribe
Sign In

Company Profiles
Target Profiles
Product Profiles

Free Trial Information

Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles

BioCentury | Sep 26, 2018

Company News

Management tracks: Merck clears path for Frazier to remain CEO

...CSO John Patton. Whitaker joins the company from respiratory disease company Vast Therapeutics Inc. (formerly Novoclem Therapeutics Inc....

Items per page:

10

1 - 1 of 1

BioCentury | Sep 26, 2018

Company News

Management tracks: Merck clears path for Frazier to remain CEO

...CSO John Patton. Whitaker joins the company from respiratory disease company Vast Therapeutics Inc. (formerly Novoclem Therapeutics Inc....

Items per page:

10

1 - 1 of 1

Products & Solutions

Latest Articles
Products Overview
简体中文
日本語
한국어
BCIQ
Conferences
White Papers

About Biocentury

Company Overview
Management
Editorial & Research
Scientific Advisory Board

Contact

Contact Us
Advertising & Sponsorship
Reprints & Permissions
Career Opportunities
Forgot Password

Privacy & Legal

User Agreement
Terms of Use
Privacy Policy
Your California Privacy Rights
Use of Images
Market data

Follow Us

© 2021 BioCentury Inc. All Rights Reserved. Terms & Conditions | Privacy Policy

Previous page

Next page